Aehr Test Systems (NASDAQ:AEHR) Shares Bought by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC raised its holdings in Aehr Test Systems (NASDAQ:AEHR) by 5.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,436 shares of the semiconductor company’s stock after buying an additional 2,123 shares during the period. Thompson Siegel & Walmsley LLC owned about 0.14% of Aehr Test Systems worth $1,627,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in AEHR. Ameriprise Financial Inc. acquired a new stake in shares of Aehr Test Systems during the first quarter worth about $42,623,000. Point72 Asset Management L.P. increased its position in shares of Aehr Test Systems by 114.1% during the fourth quarter. Point72 Asset Management L.P. now owns 721,646 shares of the semiconductor company’s stock worth $14,505,000 after purchasing an additional 384,636 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Aehr Test Systems by 2,389.5% during the first quarter. Dimensional Fund Advisors LP now owns 328,192 shares of the semiconductor company’s stock worth $10,185,000 after purchasing an additional 315,009 shares in the last quarter. Next Century Growth Investors LLC acquired a new stake in shares of Aehr Test Systems during the first quarter worth about $8,952,000. Finally, Renaissance Technologies LLC increased its position in shares of Aehr Test Systems by 718.1% during the first quarter. Renaissance Technologies LLC now owns 294,500 shares of the semiconductor company’s stock worth $9,135,000 after purchasing an additional 258,500 shares in the last quarter. Institutional investors and hedge funds own 67.80% of the company’s stock.

Aehr Test Systems Trading Down 0.7 %

Shares of AEHR opened at $25.22 on Friday. Aehr Test Systems has a twelve month low of $17.05 and a twelve month high of $54.10. The stock’s 50 day moving average is $35.96 and its two-hundred day moving average is $39.50. The firm has a market capitalization of $726.31 million, a PE ratio of 39.41 and a beta of 2.11.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings results on Thursday, October 5th. The semiconductor company reported $0.16 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.02). The firm had revenue of $20.62 million for the quarter, compared to analysts’ expectations of $21.80 million. Aehr Test Systems had a return on equity of 26.53% and a net margin of 24.89%. On average, sell-side analysts predict that Aehr Test Systems will post 0.97 EPS for the current year.

Insider Transactions at Aehr Test Systems

In other news, VP Alistair N. Sporck sold 955 shares of the business’s stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $37.65, for a total transaction of $35,955.75. Following the sale, the vice president now owns 11,988 shares of the company’s stock, valued at approximately $451,348.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Howard T. Slayen acquired 700 shares of the business’s stock in a transaction that occurred on Wednesday, October 11th. The stock was purchased at an average cost of $40.20 per share, for a total transaction of $28,140.00. Following the transaction, the director now directly owns 186,989 shares of the company’s stock, valued at approximately $7,516,957.80. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Alistair N. Sporck sold 955 shares of Aehr Test Systems stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $37.65, for a total value of $35,955.75. Following the transaction, the vice president now owns 11,988 shares of the company’s stock, valued at $451,348.20. The disclosure for this sale can be found here. Corporate insiders own 11.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on AEHR shares. TheStreet lowered Aehr Test Systems from a “b-” rating to a “c+” rating in a report on Friday, October 27th. StockNews.com started coverage on Aehr Test Systems in a report on Thursday, October 5th. They set a “hold” rating on the stock.

Aehr Test Systems Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.